Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy

অনুযায়ী Morrow, Phuong K., Wulf, Gerburg M., Ensor, Joe, Booser, Daniel J., Moore, Julia A., Flores, Peter R., Xiong, Yan, Zhang, Siyuan, Krop, Ian E., Winer, Eric P., Kindelberger, David W., Coviello, Jeanna, Sahin, Aysegul A., Nuñez, Rodolfo, Hortobagyi, Gabriel N., Yu, Dihua, Esteva, Francisco J.
প্রকাশিত 2011